AlphaFold predicted structure
CTSD · P07339

Mean pLDDT
85.0/ 100
Confident
412 residues
Confidence breakdown
- Very high(≥ 90)62%
- Confident(70–90)20%
- Low(50–70)10%
- Very low(< 50)9%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cathepsin D
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalLysosomal storage disorder
BIALLELIC, autosomal or pseudoautosomalNeuronal ceroid lipofuscinosis
BIALLELIC, autosomal or pseudoautosomalRetinal disorders
BIALLELIC, autosomal or pseudoautosomal+4 more panels — install the extension to see the full list inline on any page.
neuronal ceroid lipofuscinosis 10
CLN10 disease
neuronal ceroid lipofuscinosis
CLN1 disease
Congenital neuronal ceroid lipofuscinosis
neurodegenerative disease
infantile neuronal ceroid lipofuscinosis
lysosomal storage disease
juvenile neuronal ceroid lipofuscinosis 10
late infantile neuronal ceroid lipofuscinosis 10
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cathepsin D
Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease
CTSD · P07339

Mean pLDDT
85.0/ 100
Confident
412 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0